Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease
Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands
Objective: To investigate genetic variability in CYP2B6, PCB levels and Parkinson's disease in the Faroese. Background: Polychlorinated biphenyls (PCBs) are persistent man-made highly toxic pollutants…Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy
Objective: To describe a patient with bilateral cerebral and cerebellar calcification secondary to a hypoparathyroidsm. Background: Fahr's Syndrome (FS) is a rare disorder and may…Sleep disorders in progressive supranuclear palsy
Objective: Assessment of incidence of insomnia in PSP, its connection with motor, neuropsychological and behavior disorders, evaluation of impact on the quality of life. Background:…EBM review on the diagnostic work-up of multiple system atrophy
Objective: The International Parkinson and Movement Disorder Society (MDS)-endorsed MSA study group (MODIMSA) identified an urgent need to develop evidence-based recommendations for the diagnostic work-up…Zolpidem ameliorates the freezing of gait in a patient with PAGF (pure akinesia with freezing of gait)-the possible neural mechanism
Objective: To investigate the possible mechanism of amelioration of freezing of gait (FOG) in a patient with PAGF (Pure Akinesia with Freezing of Gait) by…Parkinson’s syndrome as possible manifestation of lamina quadrigemina tumor or inflammation
Objective: Objective of this report is to discuss the case of Parkinson's syndrome (PS) in 22 y.o. patient on the background of the pathological process…Dat-SPECT in multiple system atrophy (MSA)
Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum with the patients with MSA, and compared between subtypes and disease duration…Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study
Objective: The aim of the present study was to determine the effects of istradefylline, adenosine A2A receptor antagonist on lower urinary tract symptoms (LUTS) in…Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report
Objective: To describe prodromal symptoms or signs of Parkinson's disease (PD) in a type 1 Gaucher Disease cohort (GD). Background: Mutations in the acid b-glucocerebrosidase…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 207
- Next Page »